Get the Stockscreener App
4.56
1.08%
-0.05
After Hours:
4.34
-0.22
-4.82%
Scpharmaceuticals Inc stock is traded at $4.56, with a volume of 377.72K.
It is down -1.08% in the last 24 hours and down -10.41% over the past month.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
See More
Previous Close:
$4.61
Open:
$4.58
24h Volume:
377.72K
Relative Volume:
1.40
Market Cap:
$230.63M
Revenue:
$17.63M
Net Income/Loss:
$-57.71M
P/E Ratio:
-3.4286
EPS:
-1.33
Net Cash Flow:
$-60.45M
1W Performance:
-5.20%
1M Performance:
-10.41%
6M Performance:
-9.16%
1Y Performance:
-35.96%
1-Day Range:
$4.33
$4.63
1-Week Range:
$4.31
$4.88
52-Week Range:
$3.24
$7.10
Scpharmaceuticals Inc Stock (SCPH) Company Profile
Name
Scpharmaceuticals Inc
Sector
Industry
Phone
617-517-0730
Address
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-22 | Initiated | Cowen | Outperform |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Oct-11-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-02-22 | Initiated | Maxim Group | Buy |
| Sep-09-21 | Initiated | SVB Leerink | Mkt Perform |
| Oct-15-19 | Initiated | H.C. Wainwright | Buy |
| Jan-30-19 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
View All
Scpharmaceuticals Inc Stock (SCPH) Latest News
scPharmaceuticals Inc. (NASDAQ:SCPH) Short Interest Down 15.0% in September - MarketBeat
Holdings of scPharmaceuticals Inc (SCPH) are aligned with the stars - SETE News
Craig Hallum gives a Buy recommendation for scPharmaceuticals Inc (SCPH) - Knox Daily
King Luther Capital Management Corp Purchases 752,005 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year - Yahoo Finance
Rice Hall James & Associates LLC Has $2.16 Million Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
scPharmaceuticals Inc [SCPH] Investment Guide: What You Need to Know - Knox Daily
scPharmaceuticals Inc. (NASDAQ:SCPH) Stock Holdings Increased by AIGH Capital Management LLC - MarketBeat
scPharmaceuticals Inc [SCPH] 10% Owner makes an insider purchase of 500,000 shares worth 2.0 million. - Knox Daily
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
scPharmaceuticals’ $125 Million Senior Secured Term Loan - Global Legal Chronicle
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Do investors need to be concerned about scPharmaceuticals Inc (SCPH)? - US Post News
There is no way scPharmaceuticals Inc (SCPH) can keep these numbers up - SETE News
scPharmaceuticals Inc (SCPH) rating initates by Craig Hallum - Knox Daily
Assenagon Asset Management S.A. Boosts Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
scPharmaceuticals Inc. to Post Q3 2024 Earnings of ($0.28) Per Share, HC Wainwright Forecasts (NASDAQ:SCPH) - MarketBeat
Craig Hallum’s latest rating for SCPH stock - Knox Daily
After losing 35% in the past year, scPharmaceuticals Inc. (NASDAQ:SCPH) institutional owners must be relieved by the recent gain - Yahoo Finance
scPharmaceuticals (NASDAQ:SCPH) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
scPharmaceuticals stock rated a Buy amid revenue growth - Investing.com
scPharmaceuticals stock rated a Buy amid revenue growth - Investing.com India
scPharmaceuticals (FRA:2SX) Inventory-to-Revenue : 1.54 (As of Jun. 2024) - GuruFocus.com
Public Equity Report: AnaptysBio, Avidity draw nine-digit offerings - BioCentury
Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? - Yahoo Finance
scPharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Brokers Issue Forecasts for scPharmaceuticals Inc.'s Q2 2024 Earnings (NASDAQ:SCPH) - MarketBeat
OrbiMed Advisors LLC buys $2 million in scPharmaceuticals stock By Investing.com - Investing.com South Africa
OrbiMed Advisors LLC buys $2 million in scPharmaceuticals stock By Investing.com - Investing.com Canada
OrbiMed Advisors LLC buys $2 million in scPharmaceuticals stock - Investing.com India
OrbiMed Advisors LLC buys $2 million in scPharmaceuticals stock - Investing.com
Earnings call: scPharmaceuticals reports growth and label expansion By Investing.com - Investing.com Australia
Earnings call: scPharmaceuticals reports growth and label expansion By Investing.com - Investing.com Canada
Earnings call: scPharmaceuticals reports growth and label expansion - Investing.com
Earnings call: scPharmaceuticals reports growth and label expansion By Investing.com - Investing.com India
Earnings call: scPharmaceuticals reports growth and label expansion By Investing.com - Investing.com UK
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2024 Earnings Call Transcript - Insider Monkey
Q2 2024 EPS Estimates for scPharmaceuticals Inc. (NASDAQ:SCPH) Decreased by Leerink Partnrs - Defense World
scPharmaceuticals Inc (SCPH) Q2 2024 Earnings Call Transcript Hi - GuruFocus.com
SCPH Stock Earnings: scPharmaceuticals Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
scPharmaceuticals Inc Reports Q2 2024 Revenue of $8.1 Million, G - GuruFocus.com
ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates - MSN
ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance
Check Out scPharmaceuticals Inc (SCPH)’s Trade Data Rather Than the Analysts’ Views - SETE News
A Tale of Resilience: scPharmaceuticals Inc Amid Stock Market Turbulence - The InvestChronicle
Latham & Watkins Advises scPharmaceuticals on Growth Financings - Legal Desire News Network
Latham & Watkins Advises scPharmaceuticals on Growth Financings - Latham & Watkins LLP -
Scpharmaceuticals Inc Stock (SCPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):